NRX Pharmaceuticals (NRXP) Q1 2026 Earnings

23MarConfirmed
Q2 2025
Q2 2025
Q4 2025
Q1 2026
-0.98
-0.65
-0.32
0.01

Details

Expected EPS
0.006625
Actual EPS
-0.04
Surprise EPS
-0.05
Surprise Percent
+703.77%

Description

NRX Pharmaceuticals (NRXP) has reported earnings of -0.04 per share for Q1 2026.

0 Comments

Share your thoughts